On the EBRT theme, I had opted for HDR Brachytherapy with a top of 15 sessions of EBRT 2 weeks after the brachy. 6 months HT (bicalutamide) before and after.
Anyway, I had googled my oncologist at Clatterbridge some time ago and she was a leading light in a trial reducing EBRT to 20 sessions but with more sophisticated targeting. In short it deliver much higher doses to the actual tumor than to the rest of the prostate. I raised it at my appointment today and I was told that the trial had ended but that the consultant would consider me for the 20 session treatment outside of the trial. It wouldn't affect the speed of the process as the HT would be required in any event.
Tempted I must admit as it cuts out the brachy (and a night in hospital) and is by definition a bit less invasive although they do have to place markers in the prostate but this can be done as a day procedure.
I have another meeting with her in February. Apparently high level meetings will have taken place by then with the possibility of rolling it out more generally.